Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors

American Journal of Pathology

Volumn 153, Issue 6, 1998, Pages 1775-1785

  Germolec, Dori R ^a   Spalding, Judson ^a   Yu, Hsin Su ^b   Chen, G S ^b   Simeonova, Petia P ^c   Humble, Michael C ^a   Bruccoleri, Alessandra ^a   Boorman, Gary A ^a   Foley, Julie F ^a   Yoshida, Takahiko ^d   Luster, Michael I ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE; KERATINOCYTE GROWTH FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN DISEASE; SKIN PAPILLOMA; SKIN TUMOR; TRANSGENIC MOUSE;

EID: 0031740709     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65692-1     Document Type: Article

References (59)

1. US Environmental Protection Agency: Special Report on Ingested Inorganic Arsenic: Skin Cancer and Nutritional Essentiality. Risk Assessment Forum. Washington, DC, US Environmental Protection Agency, 1987
2. Nriagu JO: Arsenic in the Environment. II. Human Health and Ecosystem Effects. New York, Wiley and Sons, 1994
3. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto P, Duggan HM, Wood R, Kornett MJ, Smith MT: Cancer risks from arsenic in drinking water. Environ Health Perspect 1992, 97: 259-267
4. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin JS, Huang CH, Chen CJ: Incidence of internal cancers and ingested inorganic arsenic: a 7-year follow-up study in Taiwan. Cancer Res 1995, 55:1296-1300
5. Maloney ME: Arsenic in dermatology. Dermatol Surg 1996, 22:301-304
6. Chai C-Y, Yu H-S, Yen H-T, Tsai K-B, Chen S-S, Yu C-L: The inhibitory effect of UVB irradiation on the expression of p53 and Ki-67 proteins in arsenic-induced Bowen's disease. J Cutan Pathol 1997, 24:8-13
7. International Agency for Research on Cancer (IARC): Arsenic and arsenic compounds. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans: Overall Evaluations of Carcinogenicity. An Update of IARC 1987, Lyon, France. Monographs 1 to 42, suppl 7, pp 100-106
8. Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y: Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985, 45:5895-5899
9. Kanisawa M, Schroder HA: Life term studies on the effect of trace elements on spontaneous tumors in mice and rats. Cancer Res 1969, 29:892-895
10. Boutwell R: Feed additives: a carcinogenicity evaluation of potassium arsenite (KAsO2) and arsanillic acid. J Ag Food Chem 1963, 11:381-386
11. Baroni C, Van Esch G, Saffiotti U: Carcinogenesis tests of two inorganic arsenicals. Arch Environ Health 1963, 7:668-674
12. Rossman TG, Stone D, Moling M, Troll W: Absence of arsenite mutagenicity in E. coli and Chinese hamster cells. Environ Mutagen 1980, 2:371-379
13. Brown JL, Kitchin KT: Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: relevance to arsenic carcinogenesis. Cancer Lett 1996, 98:227-231
14. Germolec DR, Yoshida T, Gaido K, Wilmer JL, Simeonova PP, Kayama F, Burleson F, Dong W, Lange RW, Luster MI: Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol Appl Pharmacol 1996, 141:308-318
15. Kachinskas D, Phillips MA, Qin Q, Stokes JD, Rice RH: Arsenate perturbation of human keratinocyte differentiation. Cell Growth Differ 1994, 5:1235-1241
16. Burleson FG, Simeonova PP, Germolec DR, Luster MI: Dermatotoxic chemical stimulation of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes. Research Commun Mol Pathol Pharmacol 1996, 93:131-148
17. Klimecki WT, Borchers AH, Egbert RE, Nagle RB, Carter DE, Bowden GT: Effects of acute and chronic arsenic exposure of human-derived keratinocytes in an in vitro human skin equivalent system: a novel model of human arsenicism. Toxicol In Vitro 1997, 11:89-98
18. Jha AN, Noditi M, Nilsson R, Natarajan AT: Genotoxic effects of sodium arsenic on human cells. Mutation Res 1992, 284:215-221
19. Lee T-C, Tanaka N, Lamb PW, Gilmer TM, Barrett JC: Induction of gene amplification by arsenic. Science 1988, 241:79-81
20. Mass M, Wang L: Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutation Res 1997, 386: 263-278
21. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP: Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 1997, 94:10907-10912
22. Luger TA Schwarz T: Epidermal cell-derived cytokines. Skin Immune System. Edited by Bos JD. Boca Raton, FL, CRC Press, 1990, pp 257-291
23. Vasunia KB, Miller ML, Puga A, Baxter CS: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers. Carcinogenesis 1994, 15: 653-660
24. Gottlieb AB, Chang CK, Posnett DN, Fanelli B, Tam JP: Detection of transforming growth factor α in normal malignant and hyperproliferative human keratinocytes. J Exp Med 1988, 167:670-675
25. Finzi E, Kilkenny A, Strickland JE, Balaschak M, Bringman T, Derynck R, Aaronson S, Yuspa SH: TGF-α stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression. Mol Carcinog 1988, 1:7-12
26. Furstenberger G, Rogers M, Schnapke R, Bauer G, Hofler P, Marks F: Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effects of wounding in initiated NMRI mouse skin. Int J Cancer 1989, 43:915-921
27. Vassar R, Fuchs E: Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev 1991, 5:714-727
28. Dominey AM, Want XJ, King LE, Nanney LB, Gagne TA, Sellheyer K, Bundman DS, Longley MA, Rothnagel JA, Greenhalgh DA, Roop DR: Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ 1993, 4:1071-1082
29. Thorgeirsson SS, Santoni-Rugui E: Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor α and hepatocyte growth factor in hepatocarcinogenesis. Br J Clin Pharmacol 1996, 42:43-52
30. Amundadottir LT, Mass SJ, Berchem GJ, Johnson MD, Dickson RB: Cooperation of TGF-α and c-myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene 1996, 13:757-765
31. Takagi H, Sharp R, Takayama H, Anver MR, Ward JM, Merlino G: Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor-α transgenic mice. Cancer Res 1993, 53:4329-4336
32. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL Lee DC: Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990, 61:1121-1135
33. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61:1137-1146
34. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ: Development of mammary hyperplasia and neoplasia in MMTV-TGF-α transgenic mice. Cell 1990, 61:1147-1155
35. Humble MC, Szczesnial CJ, Luetteke NC, Spalding JW, Cannon RE, Hansen LA, Lee DC, Tennant RW: TGF-α is dispensable for skin tumorigenesis in Tg.AC mice. Toxicol Pathol 1998 (in press)
36. Tennant RW, Spalding J: Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens. Environ Health Perspect 1996, 104:1095-1104
37. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P: v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 1990, 87:9178-9182
38. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 1968, 40:453-463
39. Molin L, Wester PO: The estimated daily losses of trace elements from normal skin by desquamation. Scand J Clin Lab Invest 1976, 36:679-688
40. Cardiff RD, Leder A, Kuo A, Pattengale PK, Leder P: Multiple tumor types appears in transgenic mouse with a RAS oncogene. Am J Pathol 1993, 142:1199-1207
41. Spalding JW, Momma J, Elwell MR, Tennant RW: Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Carcinogenesis 1993, 14:1335-1341
42. Robertson FM, Bijur GN, Oberyszyn AS, Pellegrini AE, Boros LG, Sabourin LK, Oberyszyn TM: Granulocyte-macrophage colony stimulating factor gene expression and function during tumor formation. Carcinogenesis 1994, 15:1012-1029
43. Hansen LA, Tennant R: Follicular origin of epidermal papillomas in v-Ha-ras transgenic Tg.AC mouse skin. Proc Natl Acad Sci USA 1994, 91:7822-7826
44. Partridge M, Green MR, Langdon JD, Feldmann M: Production of TGF-α and TGF-β by cultured keratinocytes, skin, and oral squamous cell carcinomas: potential autocrine regulation of normal and malignant epithelial cell proliferation. Br J Cancer 1989, 60:542-548
45. Grant JJH, Howes G, McKee PH: Transforming growth factor-β expression in situ epidermal neoplasia. Clin Exp Dermatol 1995, 20: 208-212
46. Imamoto A, Beltran LM, DiGiovanni J: Evidence for autocrine/paracrine growth stimulation by transforming growth factor-α during the process of skin tumor promotion. J Mol Carcinog 1991, 4:52-60
47. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ, Ellingsworth L, Derynck R, Voorhees JJ: Overexpression of transforming growth factor-α in psoriatic epidermis. Science 1989, 243: 811-814
48. Shibata MA, Ward JM, Merlino G: Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-α-induced epidermal growth factor receptor activation but not p53 inactivation. Mol Carcinog 1997, 18:160-170
49. Lee E, Punnonen K, Cheng C, Glick A, Dlugosz A, Yuspa SH: Analysis of phospholipid metabolism in murine keratinocytes transformed by the v-ras oncogene: relationship of phosphatidylinositol turnover and cytokine stimulation to the transformed phenotype. Carcinogenesis 1992, 13:2367-2373
50. Glick AB, Sporn MB, Yuspa SH: Altered regulation of TGF-β1 and TGF-α in primary keratinocytes and papillomas expressing v-Ha-ras. Mol Carcinog 1991, 4:210-219
51. Shin TH, Patterson AJ, Kudlow JE: p53 stimulates transcription from the human transforming growth factor α promoter: a potential growth-stimulatory role for p53. Mol Cell Biol 1995, 15:4694-4701
52. Braunstein S, Kaplan G, Gottlieb AB, Schwartz M, Walsh G, Abalos RM, Fajardo TT, Guido LS, Krueger JG: GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol 1994, 103:601-604
53. Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S: Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990, 94:1013-1073
54. Kaplan G, Walsh G, Guido LS, Meyn P, Burkhardt RA, Abalos RM, Barker J, Frindt PA, Fajardo TT, Celona R, Cohn ZA: Novel responses of human skin to intradermal recombinant granulocyte/macrophage colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 1992, 175:1717-1728
55. Lontz W, Sirsho A, Liu W, Lindberg M, Rollman O, Torma H: Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1β and TNF-α. Free Radical Biol Med 1995, 18:349-355
56. Uyemora K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705
57. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G: Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. J Clin Invest 1997, 99:3009-3017
58. Koury MJ, Balmain A, Pragnell IB: Induction of granulocyte-macrophage colony-stimulating activity in mouse skin by inflammatory agents and tumor promoters. EMBO J 1983, 2:1877-1882
59. 74AS-arsenite or arsenate. Acta Pharmacol Toxicol 1982, 51:253-259